A Better Treatment for Parkinson’s?
(Ivanhoe Newswire) -- Close to 90,000 patients a year are treated for Parkinson’s disease. Deep Brain Stimulation (DBS) is the standard treatment, but it can be an expensive and long procedure with serious side effects. Now, new research in Switzerland has uncovered a possible answer for a more successful treatment.
Researchers at the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland report that soft arrays of miniature electrodes open up new possibilities for a more accurate DBS.
Professor Philippe Renaud announced the start of clinical trials with early, promising results in patients. He also describes new ultra-flexible electronics that can conform to the contours of the brainstem for treating other disorders.
"Although Deep Brain Stimulation has been used for the past two decades, we see little progress in its clinical outcomes. Microelectrodes have the potential to open new therapeutic routes, with more efficiency and fewer side effects through a much better and finer control of electrical activation zones,” Renaud was quoted as saying.
SOURCE: American Association for the Advancement of Science, February 2013